Formosan Union Chemical Corp. (TPE:1709)
Taiwan · Delayed Price · Currency is TWD 16.65
0.00 (0.00%)
At close: Feb 11, 2026
Formosan Union Chemical Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| 9,165 | 10,304 | 9,432 | 10,571 | 9,199 | 8,482 | |
Revenue Growth (YoY) | -11.28% | 9.25% | -10.77% | 14.92% | 8.46% | -3.58% |
Cost of Revenue | 7,915 | 8,833 | 8,277 | 8,623 | 7,061 | 6,995 |
Gross Profit | 1,250 | 1,472 | 1,156 | 1,948 | 2,138 | 1,487 |
Selling, General & Admin | 646.03 | 778.2 | 660.7 | 848.98 | 851.3 | 718.1 |
Research & Development | 64.51 | 71.41 | 61.6 | 71.72 | 69.29 | 63.09 |
Other Operating Expenses | -1.36 | 1.88 | -0.26 | -0.9 | -0.75 | -2.82 |
Operating Expenses | 709.18 | 851.49 | 722 | 919.73 | 919.07 | 778.48 |
Operating Income | 540.67 | 620.13 | 433.7 | 1,029 | 1,219 | 708.84 |
Interest Expense | -39.41 | -45.25 | -47.24 | -33.21 | -22.06 | -27.31 |
Interest & Investment Income | 71.82 | 80.08 | 54.01 | 40.38 | 23.31 | 33.31 |
Earnings From Equity Investments | -19.63 | -5.25 | -2.42 | 37.23 | 58.45 | 13.87 |
Currency Exchange Gain (Loss) | 10.51 | 68.51 | 16.25 | 136.32 | -10.94 | -9.4 |
Other Non Operating Income (Expenses) | 80.31 | 31.73 | 9.42 | 19.86 | 18.1 | 30.06 |
EBT Excluding Unusual Items | 644.26 | 749.95 | 463.72 | 1,229 | 1,286 | 749.36 |
Impairment of Goodwill | - | - | - | - | -2.9 | - |
Gain (Loss) on Sale of Investments | 3.9 | 137.76 | 31.54 | 106.13 | 19.38 | 0.42 |
Gain (Loss) on Sale of Assets | -1.36 | 0.21 | 0.19 | 6.43 | 55.18 | -36.34 |
Asset Writedown | - | - | - | - | -347.13 | - |
Pretax Income | 646.81 | 887.93 | 495.45 | 1,342 | 1,010 | 713.44 |
Income Tax Expense | 155.97 | 155.22 | 83.73 | 260.58 | 91.02 | 173.78 |
Earnings From Continuing Operations | 490.84 | 732.71 | 411.72 | 1,081 | 919.06 | 539.66 |
Minority Interest in Earnings | -0 | 0.87 | 6.47 | 3.32 | 28.53 | 15.13 |
Net Income | 490.84 | 733.58 | 418.19 | 1,085 | 947.59 | 554.79 |
Net Income to Common | 490.84 | 733.58 | 418.19 | 1,085 | 947.59 | 554.79 |
Net Income Growth | -29.84% | 75.42% | -61.44% | 14.46% | 70.80% | 157.73% |
Shares Outstanding (Basic) | 477 | 477 | 477 | 477 | 477 | 477 |
Shares Outstanding (Diluted) | 478 | 478 | 478 | 479 | 478 | 478 |
Shares Change (YoY) | 0.09% | 0.07% | -0.18% | 0.07% | 0.02% | -3.38% |
EPS (Basic) | 1.03 | 1.54 | 0.88 | 2.27 | 1.99 | 1.16 |
EPS (Diluted) | 1.02 | 1.53 | 0.88 | 2.27 | 1.98 | 1.16 |
EPS Growth | -30.43% | 74.52% | -61.38% | 14.65% | 70.69% | 166.68% |
Free Cash Flow | 707.81 | 686.22 | 737.96 | 1,041 | 497.43 | 1,316 |
Free Cash Flow Per Share | 1.48 | 1.44 | 1.54 | 2.17 | 1.04 | 2.75 |
Dividend Per Share | 0.800 | 0.800 | 0.600 | 1.800 | 1.500 | 1.200 |
Dividend Growth | 33.33% | 33.33% | -66.67% | 20.00% | 25.00% | 140.00% |
Gross Margin | 13.64% | 14.28% | 12.25% | 18.43% | 23.24% | 17.54% |
Operating Margin | 5.90% | 6.02% | 4.60% | 9.73% | 13.25% | 8.36% |
Profit Margin | 5.36% | 7.12% | 4.43% | 10.26% | 10.30% | 6.54% |
Free Cash Flow Margin | 7.72% | 6.66% | 7.82% | 9.85% | 5.41% | 15.51% |
EBITDA | 748.75 | 829.22 | 647.8 | 1,249 | 1,458 | 987.15 |
EBITDA Margin | 8.17% | 8.05% | 6.87% | 11.81% | 15.85% | 11.64% |
D&A For EBITDA | 208.09 | 209.09 | 214.1 | 220.05 | 239.47 | 278.31 |
EBIT | 540.67 | 620.13 | 433.7 | 1,029 | 1,219 | 708.84 |
EBIT Margin | 5.90% | 6.02% | 4.60% | 9.73% | 13.25% | 8.36% |
Effective Tax Rate | 24.11% | 17.48% | 16.90% | 19.42% | 9.01% | 24.36% |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.